PSNCBAM-1 is a negative allosteric modulator of the cannabinoid CB1 receptor.[1][2]
Identifiers | |
---|---|
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C22H21ClN4O |
Molar mass | 392.89 g·mol−1 |
3D model (JSmol) | |
| |
|
See also
editReferences
edit- ^ German N, Decker AM, Gilmour BP, Gay EA, Wiley JL, Thomas BF, Zhang Y (September 2014). "Diarylureas as Allosteric Modulators of the Cannabinoid CB1 Receptor: Structure–Activity Relationship Studies on 1-(4-Chlorophenyl)-3-{3-[6-(pyrrolidin-1-yl)pyridin-2-yl]phenyl}urea (PSNCBAM-1)". Journal of Medicinal Chemistry. 57 (18): 7758–7769. doi:10.1021/jm501042u. PMC 4175001. PMID 25162172.
- ^ Horswill JG, Bali U, Shaaban S, Keily JF, Jeevaratnam P, Babbs AJ, Reynet C, Wong Kai In P (November 2007). "PSNCBAM-1, a novel allosteric antagonist at cannabinoid CB1 receptors with hypophagic effects in rats". British Journal of Pharmacology. 152 (5): 805–814. doi:10.1038/sj.bjp.0707347. PMC 2190018. PMID 17592509.